The latest news from the global pharmaceutical industry. Below you will find news and information to keep you up-to-date with what is happening in your industry. Coverage includes regulatory approvals, recall announcements, mergers and acquisitions, personnel news and appointments, new facility and facility expansion updates, collaborations and agreements, and financial updates.
Thursday, November 21, 2019
Seelos announced the FDA has granted Fast Track designation to its new intranasal racemic ketamine program for the treatment of Acute Suicidal ...
read more
Monday, November 18, 2019
OWC Pharmaceutical and STENOCARE have signed a strategic MoU to develop and commercialize new cannabis-based medical products.
read more
Wednesday, November 13, 2019
Oramed announced positive results from the trial evaluating the efficacy and safety of ORMD-0801 for diabetes.
read more
Tuesday, November 12, 2019
The FDA communicated the ANDA for generic Paliperidone Palmitate Extended-Release Injectable Suspension prefilled syringes, is accepted for review. ...
read more
Monday, November 11, 2019
American Health Packaging is voluntarily recalling eight lots of Ranitidine Syrup 150 mg/10 mL Liquid Unit Dose Cups to the consumer level.
read more
Thursday, November 07, 2019
Foamix announced the USPTO has issued a patent, reciting waterless compositions comprising a retinoid and a tetracycline antibiotic, as well as ...
read more
Wednesday, November 06, 2019
Medtronic is recalling MiniMed Model 500 Remote Control and 503 Remote Transmitter (MMT-500 and MMT-503) insulin pumps due to potential cybersecurity ...
read more
Tuesday, November 05, 2019
The FDA has taken a number of actions over the last several years to monitor the safety of the Essure permanent birth control device and has regularly...
read more
Thursday, October 31, 2019
Biostage has submitted an IND application to the FDA for the Company's lead product candidate, the Cellspan Esophageal Implant.
read more
Tuesday, October 29, 2019
DiscGenics has received the go-ahead from an independent DSMC to enroll the final 24 patients in its first-in-human U.S. clinical study of IDCT.
read more
Wednesday, October 23, 2019
Vitalis announced its goal of commercializing its lead product candidate VTS-72 in 2021.
read more
Wednesday, October 23, 2019
The FDA has expanded the label for Fiasp 100 u/mL to include use in insulin infusion pumps for the improvement of glycemic control in adults with type...
read more
Bryn Pharma has entered into an agreement with Aptar Pharma for Aptar's novel Bidose nasal device for the delivery of epinephrine to treat anaphylaxis...
read more
Foamix announced the FDA has accepted for review the NDA for FMX103 topical foam.
read more
Spring Bank announced interim top-line results from the Phase 2 trial evaluating escalating doses inarigivir co-administered with Gilead Sciences’ ...
read more